Loading...
•
Mar 31, 2025
Tactile Systems Q1 2025 Earnings Report
reported financial results for the first quarter ended March 31, 2025
Key Takeaways
Tactile Medical reported a slight increase in total revenue for Q1 2025, up 0.3% year-over-year to $61.3 million. The company experienced a net loss of $3.0 million and an Adjusted EBITDA loss of $0.3 million, compared to a net loss of $2.2 million and positive Adjusted EBITDA of $1.0 million in the prior year quarter.
Total revenue for Q1 2025 was $61.3 million, a 0.3% increase from Q1 2024.
Gross margin improved to 74% in Q1 2025 from 71% in Q1 2024.
Net loss increased to $3.0 million in Q1 2025 from $2.2 million in Q1 2024.
Adjusted EBITDA was a loss of $0.3 million in Q1 2025, compared to a positive $1.0 million in Q1 2024.
Revenue by Segment
Forward Guidance
The company updated its full year 2025 financial outlook, now expecting total revenue in the range of $309 million to $315 million and adjusted EBITDA in the range of $32 million to $34 million.
Positive Outlook
- Expected full year 2025 total revenue growth of approximately 5% to 8% year-over-year.
- Anticipated full year 2025 adjusted EBITDA between $32 million and $34 million.
Challenges Ahead
- Lowered full year 2025 total revenue guidance from the previous range of $316 million to $322 million.
- Lowered full year 2025 adjusted EBITDA guidance from the previous range of $35 million to $37 million.
- Prior 2025 total revenue growth expectation was approximately 8% to 10% year-over-year.
- Prior 2025 adjusted EBITDA expectation was in the range of $35 million to $37 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...